Benzinga··Vandana SinghEli Lilly to Acquire Centessa for $6.3B, Bolstering Sleep Medicine Push
Eli Lilly to acquire Centessa Pharmaceuticals for $6.3B upfront plus $1.5B in contingent payments, gaining sleep disorder pipeline including cleminorexton candidate.
LLYCNTAacquisitionneuroscience